Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-EN | Version v5-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-07-13 | 2019-07-05 |
| Drug Identification Number | 02230019 | 02230019 |
| Brand name | VIOKACE | VIOKACE |
| Common or Proper name | Viokace 10440 | Viokace 10440 |
| Company Name | NESTLE ENTERPRISES S.A. | NESTLE ENTERPRISES S.A. |
| Ingredients | AMYLASE PROTEASE LIPASE | AMYLASE PROTEASE LIPASE |
| Strength(s) | 56400UNIT 57100UNIT 10440UNIT | 56400UNIT 57100UNIT 10440UNIT |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 100's bottle | 100's bottle |
| ATC code | A09AA | A09AA |
| ATC description | DIGESTIVES, INCL ENZYMES | DIGESTIVES, INCL ENZYMES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2019-07-12 | 2019-07-12 |
| Actual start date | ||
| Estimated end date | 2019-08-05 | 2019-08-05 |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Viokace 20880 remains in stock and available | Viokace 20880 remains in stock and available |
| Health Canada comments |